» Articles » PMID: 28288873

A 3D Model of Tumour Angiogenic Microenvironment to Monitor Hypoxia Effects on Cell Interactions and Cancer Stem Cell Selection

Overview
Journal Cancer Lett
Specialty Oncology
Date 2017 Mar 15
PMID 28288873
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Tumour microenvironment determines the fate of treatments. Reconstitution of tumour conditions is mandatory for alternative in vitro methods devoted to cancer development and the selection of therapeutic strategies. This work describes a 3D model of melanoma growth in its environment. Introducing means to mimic tumour angiogenesis, which turns on tumour progression, the model shows that melanoma tumour spheroids allow reconstitution of solid tumours with stromal cells. Angiogenesis evidenced the differential recruitment of endothelial cells (EC) from early progenitors (EEPCs) to mature ECs. Hypoxia was the key parameter that selected and stabilized melanoma cancer stem like cells (CSCs) phenotype based on aldehyde dehydrogenase expression as the best criterion. The 3D-tumour-model demonstrated the distinct reactivity of ECs toward tumour cells in terms of cellular cross-talk and humoral response. Intra-spheroid cell-to-cell membrane dye exchanges, mediated by intercellular interactions, uncovered the melanoma-to-EEPC cooperation. The resulting changes in tumour milieu were evidenced by the chemokinic composition and hypoxia-related variations in microRNA expression assessed in each cellular component of the spheroids. This method brings new tools to decipher the molecular mechanism of tumour-mediated cell recruitment and for in vitro assessment of therapeutic approaches.

Citing Articles

A polysaccharide-based hydrogel platform for tumor spheroid production and anticancer drug screening.

Lopez-Vince E, Simon-Yarza T, Wilhelm C Sci Rep. 2025; 15(1):4213.

PMID: 39905058 PMC: 11794876. DOI: 10.1038/s41598-025-87896-7.


Senolysis potentiates endothelial progenitor cell adhesion to and integration into the brain vasculature.

Lam T, Toth I, Hermenean A, Wilhelm I, Kieda C, Krizbai I Stem Cell Res Ther. 2024; 15(1):413.

PMID: 39529098 PMC: 11556082. DOI: 10.1186/s13287-024-04042-2.


Co-Delivery of an Innovative Organoselenium Compound and Paclitaxel by pH-Responsive PCL Nanoparticles to Synergistically Overcome Multidrug Resistance in Cancer.

Mathes D, Macedo L, Pieta T, Maia B, Rodrigues O, Leal J Pharmaceutics. 2024; 16(5).

PMID: 38794252 PMC: 11124783. DOI: 10.3390/pharmaceutics16050590.


Vascularized tumor models for the evaluation of drug delivery systems: a paradigm shift.

Lopez-Vince E, Wilhelm C, Simon-Yarza T Drug Deliv Transl Res. 2024; 14(8):2216-2241.

PMID: 38619704 PMC: 11208221. DOI: 10.1007/s13346-024-01580-3.


Identification of hypoxic-related lncRNAs prognostic model for revealing clinical prognostic and immune infiltration characteristic of cutaneous melanoma.

Liao C, Yang J, Chen L, Ye Z Aging (Albany NY). 2024; 16(4):3734-3749.

PMID: 38364250 PMC: 10929800. DOI: 10.18632/aging.205556.